GilharAUllmannYBerkutzkiT. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp expiants on SCID mice. J Clin Invest1998; 101:62–67.
2.
JackowCDhamNHordinskyM. Genetic basis of alopecia areata: Linkage analysis. Paper delivered at the Third International Workshop on Alopecia Areata, Washington, DC, November 1998.
3.
ColombeBWLouCDPriceVH. Genetic basis of alopecia areata: HLA in longstanding disease. Paper presented at the Third International Workshop on Alopecia Areata, Washington, DC, November 1998.
4.
LuiHTangLMcLeanDI. Leflunomide in the alopecia areata DEBR rat. Paper presented at the Third International Workshop on Alopecia Areata, Washington, DC, November 1998.
5.
Freyschmidt-PaulPSeiterSZollerM. Treatment with anti-CD44V10 monoclonal antibodies inhibit the onset of alopecia areata-like hair loss in C3H/HeJ mice. Paper presented at the Third International Workshop on Alopecia Areata, Washington, DC, November 1998.
6.
McElweeKRushtonDTrachyROliverR. Topical FK506: A potent immunotherapy for alopecia areata: Studies using the Dundee experimental bald rat model. Br J Dermatol1997; 137:491–497.
7.
ShapiroJSundbergJMcElweeKJ. Immunotyping profiles during immunotherapy of alopecia areata in mice and rats with diphencyprone. Paper presented at the Third International Workshop on Alopecia Areata, Washington, DC, November 1998.
8.
DalyT. Alopecia areata has low levels of the vasodilator/immunmodulator calcitonin gene-related peptide. Arch Dermatol1998; 13:1164–1165.
9.
ScholzenTArmstrongCABunnettNW. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp Dermatol1998; 7:81–96.
10.
HordinskyMEricsonM. Relationship between follicular nerve supply and alopecia. Dermatol Clin1996; 14:651–660.
